SkyView Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-38
Closed -$20K 347
2023
Q3
$20K Sell
38
-475
-93% -$245K 0.01% 323
2023
Q2
$241K Buy
513
+494
+2,600% +$207K 0.06% 345
2023
Q1
$7K Buy
+19
New +$6.41K ﹤0.01% 470
2022
Q1
Sell
-752
Closed -$208K 613
2021
Q4
$208K Buy
+752
New +$191K 0.05% 398

Other funds holding LLY

SkyView Investment Advisors's LLY Position: Q4 2023 in Review

SkyView Investment Advisors sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 38 shares — an estimated $20K sold.

SkyView Investment Advisors first reported a position in LLY in Q4 2021 and held it in 4 quarters. The position peaked at $241K in Q2 2023. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • SkyView Investment Advisors reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 38 Eli Lilly shares in Q4 2023, an estimated $20K.
  • SkyView Investment Advisors first reported a position in Eli Lilly in Q4 2021 and held it in 4 quarters.
  • SkyView Investment Advisors's Eli Lilly position peaked at $241K in Q2 2023.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on SkyView Investment Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.